| J3380 | Injection, vedolizumab, intravenous, 1 mg | 6,300 | $20 | $107.1K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 6,300 | $10 | $50.4K |
| J1306 | Injection, inclisiran, 1 mg | 3,980 | $10 | $35.8K |
| J0897 | Injection, denosumab, 1 mg | 1,500 | $20 | $27K |
| 45385 | The provider examines the colon and rectum using a colonoscope, a long, thin flexible tubular instrument with a light source and camera. He removes one or more tumors, polyps, or other lesions with a… | 70 | $200 | $13.3K |
| 45380 | The provider examines the rectum and colon using a flexible colonoscope, a tubular instrument with a light source and camera, to look for the cause of a patient's symptoms, which may include… | 80 | $60 | $5.2K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 40 | $100 | $4K |
| 43239 | The provider inserts a flexible endoscope through the mouth and down into the esophagus, stomach, and duodenum where he removes one or more tissue biopsy specimens for diagnostic analysis. | 60 | $60 | $3.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 40 | $90 | $3.5K |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 20 | $160 | $3.4K |